DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant
Status:
Terminated
Trial end date:
2021-06-04
Target enrollment:
Participant gender:
Summary
This is a single center study for the donation of HCV-positive livers to HCV negative
recipient patients, with preemptive, interventional treatment to prevent HCV transmission
upon transplantation.